CELL-SELECTOR
DEAD

Serial Number

86284654

Owner

NISSAN CHEMICAL INDUSTRIES, LTD.

Attorney

Jeffrey H. Kaufman

Filing Date

May 19, 2014

Add to watchlist:

No watchlists yet
View on USPTO

CELL-SELECTOR Trademark

Serial Number: 86284654 • Registration: 4897070

CELL-SELECTOR is a trademark filed by NISSAN CHEMICAL INDUSTRIES, LTD. on May 19, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NISSAN CHEMICAL INDUSTRIES, LTD. (91 trademarks)

7-1, 3-CHOME, KANDA-NISHIKI-CHO
CHIYODA-KU, TOKYO , JP

Entity Type: 03

NISSAN CHEMICAL CORPORATION (108 trademarks)

CHUO-KU, TOKYO 103-6119 , JP

Entity Type: 03

Trademark Details

Filing Date

May 19, 2014

Registration Date

February 9, 2016

Published for Opposition

April 21, 2015

Cancellation Date

August 19, 2022

Goods & Services

Pharmaceutical preparations for pharmaceutical and veterinary purposes for the treatment of hematological, respiratory, central nervous system, endocrinological, circulatory and hormonal disorders, rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, anti-infective disorders, sarcoidosis, subacute myelo-optico-neuropathy, aortitis syndrome, inflammatory bowel disease, amyloidosis, striatonigral degeneration and for use in oncology; Pharmaceutical preparations for pharmaceutical and veterinary purposes for the prevention of hematological, respiratory, central nervous system, endocrinological, circulatory and hormonal disorders, rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, anti-infective disorders, sarcoidosis, subacute myelo-optico-neuropathy, aortitis syndrome, inflammatory bowel disease, amyloidosis, striatonigral degeneration and for use in oncology; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical preparations for animals for the treatment of hematological and respiratory disorders, immune system disorders and related diseases, allergic reactions, anti-infective disorders, and for use in oncology; Pharmaceutical preparations for animals for the prevention of hematological and respiratory disorders, immune system disorders and related diseases, allergic reactions, anti-infective disorders, and for use in oncology; chemical reagents for medical diagnostic purposes; nucleic acid and oligonucleotide for medical and medical diagnostic purposes; chemical reagents and reagent kit comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, medical diagnostic reagents and buffers used for detection of nucleic acid for medical and medical diagnostic purposes; chemical reagents and reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, medical diagnostic reagents and buffers used for the detection of protein for medical and medical diagnostic purposes; chemical reagents and reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, medical diagnostic reagents and buffers used for staining cells for medical and medical diagnostic purposes

Chemical preparations for general industrial manufacturing and for scientific purpose; Chemical preparations for scientific purpose and for scientific research purposes; Chemical agents for scientific purpose and research purpose, namely, chemical agents for binding cells or protein, chemical agents for chelating and sequestering; Diagnostic reagents for scientific or research purposes, other than for medical or veterinary purposes; Chemical reagents, other than for medical or veterinary purposes; Reagents used for analyzing, measuring or testing nucleotide for scientific research purposes; chemical reagents used for staining cells other than for medical or veterinary use; chemical reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, and buffers for use in biotechnology fields used for staining cells other than for medical or veterinary use; chemical reagents and reagent kits comprised of nucleic acid, oligonucleotide, deoxyribonucleic acid, protein, and buffers for use in biotechnology fields used for the detection of protein; nucleic acid and oligonucleotide for scientific research purposes; deoxyribonucleic acid for laboratory use; Protein for industrial use; enzymes for in vitro and in vivo scientific and research purposes; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 19, 2022 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 9, 2021 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 19, 2018 ASGN
REGISTERED-PRINCIPAL REGISTER
Feb 9, 2016 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Dec 31, 2015 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 21, 2015 AITU
NOTICE OF ALLOWANCE CANCELLED
Nov 11, 2015 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Nov 11, 2015 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 16, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2015 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 18, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2015 CRFA
ASSIGNED TO LIE
Feb 16, 2015 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 10, 2015 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2014 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2014 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2014 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2014 NWOS
NEW APPLICATION ENTERED
May 22, 2014 NWAP